Extraction and inhibition of enzymatic activity of botulinum neurotoxins /B1, /B2, /B3, /B4, and /B5 by a panel of monoclonal anti-BoNT/B antibodies
about
Mass Spectrometric Detection of Bacterial Protein Toxins and Their Enzymatic ActivityCharacterization of Hemagglutinin Negative Botulinum Progenitor Toxins.The thioredoxin reductase-thioredoxin system is involved in the entry of tetanus and botulinum neurotoxins in the cytosol of nerve terminals.Isolation and functional characterization of the novel Clostridium botulinum neurotoxin A8 subtype.Validation of the Endopep-MS method for qualitative detection of active botulinum neurotoxins in human and chicken serum.Development of human-like scFv-Fc antibodies neutralizing Botulinum toxin serotype BDetection of Botulinum Toxins A, B, E, and F in Foods by Endopep-MS.Implementing the Bruker MALDI Biotyper in the Public Health Laboratory for C. botulinum Neurotoxin Detection.Recommended Immunological Strategies to Screen for Botulinum Neurotoxin-Containing Samples.Recommended mass spectrometry-based strategies to identify botulinum neurotoxin-containing samples.The European AntibotABE Framework Program and Its Update: Development of Innovative Botulinum Antibodies.Finding a Silver Bullet in a Stack of Proteins.Hsp90 is involved in the entry of clostridial neurotoxins into the cytosol of nerve terminals.
P2860
Q26781284-55C66C4B-8811-4945-9F46-728C1B9CAD32Q33845176-5486114E-C36E-4B2D-ACB4-6B247D7561DBQ34313523-89EF8980-005D-4C6F-8E61-4690E582A589Q35058841-40233EF5-A237-4EF9-B153-9270E4007EA8Q35257144-D517487F-A583-48CF-8731-0275A461D725Q35779652-93E14243-B7C4-4F0E-BE5B-45B5C03282C1Q35912156-79C4E5F4-5819-47CE-8A8B-123EEBC63088Q36304649-1EEF39F4-841E-4594-903D-8FDE5A6FF6FCQ36401421-84D4E1FD-4A6C-4178-B976-E82F0F937013Q41319754-BA9EB533-22D2-4DE5-BEF4-E9E4F2D93F13Q45235847-86F75CAB-6458-4B38-9443-D1FD8FCD9384Q47302924-4F867C5B-201C-495A-BA0B-D214B028DCBEQ48163816-6AC644C3-20D0-4E15-B32F-53BCEEB170C5
P2860
Extraction and inhibition of enzymatic activity of botulinum neurotoxins /B1, /B2, /B3, /B4, and /B5 by a panel of monoclonal anti-BoNT/B antibodies
description
2011 nî lūn-bûn
@nan
2011 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年学术文章
@wuu
2011年学术文章
@zh-cn
2011年学术文章
@zh-hans
2011年学术文章
@zh-my
2011年学术文章
@zh-sg
2011年學術文章
@yue
name
Extraction and inhibition of e ...... oclonal anti-BoNT/B antibodies
@ast
Extraction and inhibition of e ...... oclonal anti-BoNT/B antibodies
@en
Extraction and inhibition of e ...... oclonal anti-BoNT/B antibodies
@nl
type
label
Extraction and inhibition of e ...... oclonal anti-BoNT/B antibodies
@ast
Extraction and inhibition of e ...... oclonal anti-BoNT/B antibodies
@en
Extraction and inhibition of e ...... oclonal anti-BoNT/B antibodies
@nl
prefLabel
Extraction and inhibition of e ...... oclonal anti-BoNT/B antibodies
@ast
Extraction and inhibition of e ...... oclonal anti-BoNT/B antibodies
@en
Extraction and inhibition of e ...... oclonal anti-BoNT/B antibodies
@nl
P2093
P2860
P356
P1433
P1476
Extraction and inhibition of e ...... oclonal anti-BoNT/B antibodies
@en
P2093
Consuelo Garcia-Rodriguez
Isin N Geren
James D Marks
James L Pirkle
Jianlong Lou
John R Barr
Leonard A Smith
Theresa J Smith
Wanda I Santana
P2860
P356
10.1186/1471-2091-12-58
P577
2011-11-15T00:00:00Z